Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sweden
Pharma
Hansa eyes FDA filing after ph. 3 win for kidney transplant med
With a late-stage win in hand, Sweden’s Hansa Biopharma is one step closer to bringing its kidney transplant drug imlifidase to the U.S.
Fraiser Kansteiner
Sep 25, 2025 12:37pm
Swedish contract manufacturer hit with FDA warning letter
Jun 9, 2025 9:09am
FDA stymies Camurus' drug over 3rd-party manufacturing issues
Oct 22, 2024 9:53am
AstraZeneca plans $135M expansion of Swedish manufacturing site
Aug 27, 2024 10:02am
Asahi Kasei moves to buy Calliditas for more than $1B
May 28, 2024 11:19am
AZ inks wind power deal with massive European energy company
Aug 9, 2023 1:22pm
